Package 64764-300-20

Brand: entyvio

Generic: vedolizumab
NDC Package

Package Facts

Identity

Package NDC 64764-300-20
Digits Only 6476430020
Product NDC 64764-300
Product ID 64764-300_24e7cbcf-82ec-4276-ba13-e719bedf3ed2
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (64764-300-20) / 5 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2014-05-20
Brand entyvio
Generic vedolizumab
Sample Package No

Linked Drug Pages (1)

ENTYVIO, ENTYVIO Pen, Entyvio ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "24e7cbcf-82ec-4276-ba13-e719bedf3ed2", "openfda": {"nui": ["N0000175775", "N0000175774"], "unii": ["9RV78Q2002"], "rxcui": ["1538137", "1538142", "2667332", "2667336", "2667339", "2667342"], "spl_set_id": ["6e94621c-1a95-4af9-98d1-52b9e6f1949c"], "pharm_class_epc": ["Integrin Receptor Antagonist [EPC]"], "pharm_class_moa": ["Integrin Receptor Antagonists [MoA]"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (64764-300-20)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "64764-300-20", "marketing_start_date": "20140520"}], "brand_name": "Entyvio", "product_id": "64764-300_24e7cbcf-82ec-4276-ba13-e719bedf3ed2", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Integrin Receptor Antagonist [EPC]", "Integrin Receptor Antagonists [MoA]"], "product_ndc": "64764-300", "generic_name": "vedolizumab", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Entyvio", "active_ingredients": [{"name": "VEDOLIZUMAB", "strength": "300 mg/5mL"}], "application_number": "BLA125476", "marketing_category": "BLA", "marketing_start_date": "20140520", "listing_expiration_date": "20271231"}